SCHEMBL13097191

SCHEMBL13097191

Cc1c(COc2ccc3c(c2)N(C(=O)CC2CCOCC2)CCC3)nc2ccc(F)cc2c1OCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 2/20 0.42
ALDH1A1 P00352 5/20 0.37
KDM4E B2RXH2 4/20 0.37
HPGD P15428 3/20 0.37
HSD17B10 Q99714 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
CNR1 P21554 2/20 0.36
CNR2 P34972 2/20 0.36
NME2 P22392 1/20 0.36
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36
PDK4 Q16654 1/20 0.36
MAPT P10636 3/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
TP53 P04637 3/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PPARG P37231 1/20 0.35
NMT2 O60551 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13106284 0.91 RORC (0.34) RORCALDH1A1KDM4EHPGDHSD17B10
SCHEMBL13097189 0.91 RORC (0.41) RORCALDH1A1KDM4EHPGDHSD17B10
SCHEMBL13097186 0.88 DHODH (0.39) RORCALDH1A1KDM4EHPGDHSD17B10
SCHEMBL13097196 0.86 RORC (0.46) RORCALDH1A1KDM4EHPGDHSD17B10
SCHEMBL13097162 0.86 RORC (0.46) RORCALDH1A1KDM4EHPGDHSD17B10
SCHEMBL13107227 0.82 OGG1 (0.39) RORCPPARGCYP11B2
SCHEMBL13097201 0.81 PTGDR2 (0.42) RORCALDH1A1CNR1CNR2LMNA
SCHEMBL13097144 0.81 RORC (0.43) RORCALDH1A1KDM4EHPGDHSD17B10
SCHEMBL13107310 0.81 AKT1 (0.36) MAPTLMNANPSR1MEN1KMT2A
SCHEMBL13097130 0.80 RORC (0.43) RORCALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367702-B2 Quinolone derivative ASTELLAS PHARMA INC. (JP) 2013-02-05 US disclosed
US-20100256113-A1 QUINOLONE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2010-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256113-A1 QUINOLONE DERIVATIVE NQO1, NQO2, NADK RORC 1412/4885ALDH1A1 524/4885KDM4E 1769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.